Bio-Rad Labs (BIO) Q4 Revs Beat Views
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $380.12 -1.55%
Revenue Growth %: -0.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -0.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, which includes tax gains and does not compare to the analyst estimate of $1.26. Revenue for the quarter came in at $620.4 million versus the consensus estimate of $619.15 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- B.Riley Starts Better Home & Finance Holding (BETR) at Buy
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
